← Leaderboards
James P. Nataro
University Of Maryland Baltimore
$22,975,369
Attributed
$22,975,369
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,118,239 · 10
By mechanism
P01$20,025,356 · 2
U19$11,863,230 · 3
R01$8,006,954 · 2
U01$2,491,750 · 1
R56$417,760 · 1
R21$313,189 · 1
Top collaborators
- James B Kaper12 shared
- Mark Donowitz8 shared
- Jennifer Foulke-Abel3 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- James B Kaper$25,841,976
- Marcelo B. Sztein$36,733,861
- Marcela F Pasetti$26,884,335
- Wilbur H. Chen$12,119,388
- Raphael Simon$3,358,086
Others in their field
Top investigators on “Escherichia Coli”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Scott J Hultgren · Washington University$41,419,179
- John L Markley · University Of Wisconsin Madison$37,032,573
- Wilhelmus G. J. Hol · University Of Washington$31,124,692
- Vanessa Sperandio · University Of Wisconsin-Madison$27,468,669
- Peter D Karp · Sri International$27,278,650
Research focus
Escherichia ColiDiarrheaPathogenPathogenesisUniversitiesMarylandResearch PersonnelIntestinesEnteroaggregative Escherichia ColiCellsShigellaMonolayerInfectionPeptide HydrolasesFundingEnteralMucinsOrganismInsightCytokineMucous MembraneVirulenceLaboratoriesEpithelial Cells
Grant awards (51)
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,122,332
P01 · FY2025 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,130,811
P01 · FY2024 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,139,153
P01 · FY2023 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models$129,396
P01 · FY2023 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,032,323
P01 · FY2022 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models$2,114,605
P01 · FY2021 · AI
Pathogenesis of E. coli and Shigella infections in human enteroid models$1,581,962
P01 · FY2020 · AI
Project 1: Pathogenesis of Enteroaggregative E. coli using human colonoids$268,600
P01 · FY2020 · AI · contact PI
Pathogenesis of E. coli and Shigella infections in human enteroid models$1,581,962
P01 · FY2019 · AI
Project 1: Pathogenesis of Enteroaggregative E. coli using human colonoids$266,563
P01 · FY2019 · AI · contact PI
Pathogenesis of E. coli and Shigella infections in human enteroid models$1,581,962
P01 · FY2018 · AI
Project 1: Pathogenesis of Enteroaggregative E. coli using human colonoids$268,600
P01 · FY2018 · AI · contact PI
Pathogenesis of E. coli and Shigella infections in human enteroid models$1,581,962
P01 · FY2017 · AI
Project 1: Pathogenesis of Enteroaggregative E. coli using human colonoids$268,600
P01 · FY2017 · AI · contact PI
Pathogenesis of E. coli and Shigella infections in human enteroid models$1,633,930
P01 · FY2016 · AI
Project 1: Pathogenesis of Enteroaggregative E. coli using human colonoids$322,595
P01 · FY2016 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$458,651
R01 · FY2014 · AI · contact PI
Clinical$257,577
U19 · FY2014 · AI · contact PI
Clinical$439,769
U19 · FY2013 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$437,824
R01 · FY2013 · AI · contact PI
Clinical$516,994
U19 · FY2012 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$513,204
R01 · FY2012 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$784,254
R01 · FY2011 · AI · contact PI
Clinical$465,935
U19 · FY2011 · AI · contact PI
Severe Enteric Disease: Pathogenesis and Response$1,512,472
U19 · FY2010 · AI
Live Attenuated Bacterial Vaccines Against Plaque$834,917
U01 · FY2010 · AI · contact PI
Clinical$495,103
U19 · FY2010 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$459,436
R01 · FY2010 · AI · contact PI
Live Attenuated Bacterial Vaccines Against Plaque$847,309
U01 · FY2009 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$443,970
R01 · FY2009 · AI · contact PI
Live Attenuated Bacterial Vaccines Against Plaque$809,524
U01 · FY2008 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$431,038
R01 · FY2008 · AI · contact PI
Autotransporters of enterobacteriaceae$417,760
R56 · FY2008 · AI · contact PI
Live Vector Vaccines Against Agents of Bioterror$1,774,057
U19 · FY2007 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$426,589
R01 · FY2007 · AI · contact PI
Live Vector Vaccines Against Agents of Bioterror$1,943,913
U19 · FY2006 · AI · contact PI
Virulence in Enteroaggregative Escherichia coli$426,534
R01 · FY2006 · AI · contact PI
Live Vector Vaccines Against Agents of Bioterror$1,930,417
U19 · FY2005 · AI
Virulence in Enteroaggregative Escherichia coli$341,929
R01 · FY2005 · AI
Live Vector Vaccines Against Agents of Bioterror$1,881,608
U19 · FY2004 · AI
VIRULENCE IN ENTEROAGGREGATIVE E COLI$408,979
R01 · FY2004 · AI
Dispersin from Enteroaggregative E. coli$313,189
R21 · FY2004 · AI
Live Vector Vaccines Against Agents of Bioterror$645,385
U19 · FY2003 · AI
VIRULENCE IN ENTEROAGGREGATIVE E COLI$397,067
R01 · FY2003 · AI
AUTOTRANSPORTERS OF ENTEROBACTERIACEAE$358,665
R01 · FY2003 · AI
VIRULENCE IN ENTEROAGGREGATIVE E COLI$356,425
R01 · FY2002 · AI
AUTOTRANSPORTERS OF ENTEROBACTERIACEAE$348,328
R01 · FY2002 · AI
VIRULENCE IN ENTEROAGGREGATIVE E COLI$374,275
R01 · FY2001 · AI
AUTOTRANSPORTERS OF ENTEROBACTERIACEAE$344,134
R01 · FY2001 · AI
VIRULENCE IN ENTEROAGGREGATIVE E COLI$366,370
R01 · FY2000 · AI
AUTOTRANSPORTERS OF ENTEROBACTERIACEAE$329,282
R01 · FY2000 · AI